PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 161 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $29,000 | -23.7% | 7,561 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $38,000 | +22.6% | 7,561 | +22.5% | 0.00% | +100.0% |
| Q3 2019 | $31,000 | -13.9% | 6,171 | +5.1% | 0.00% | -50.0% |
| Q2 2019 | $36,000 | +33.3% | 5,871 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $27,000 | +8.0% | 5,871 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $25,000 | -32.4% | 5,871 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $37,000 | -21.3% | 5,871 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $47,000 | +6.8% | 5,871 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $44,000 | +25.7% | 5,871 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $35,000 | -10.3% | 5,871 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $39,000 | -2.5% | 5,871 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $40,000 | -27.3% | 5,871 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $55,000 | – | 5,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
| Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
| Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
| Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
| BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
| PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
| Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |